Athanase Innovation AB (ATIN) Stock Statistics & Valuation Metrics

Athanase Innovation AB has a market cap or net worth of kr347.36M. The enterprise value is kr34.88B.

Athanase Innovation AB has 19,297,642 shares outstanding. The number of shares has decreased by -2.65% in one year.

Athanase Innovation AB’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.89%.

The current PE Ratio of Athanase Innovation AB is -24.43. Athanase Innovation AB’s PEG ratio is -519.92.

In the last 12 months, Athanase Innovation AB had revenue of 176.83M and earned -19.64M in profits. Earnings per share was -0.83.

In the last 12 months, operating cash flow was -14.88M and capital expenditures 0.00, giving a free cash flow of -14.88M billion.

Athanase Innovation AB pays an annual dividend of kr30.08, resulting in a dividend yield of ―

Athanase Innovation AB upcoming earnings date is Jul 11, 2025, TBA Not Confirmed.

Athanase Innovation AB as a current ratio of 5.12, with Debt / Equity ratio of 154.28%

In the past 12 months, Athanase Innovation AB has paid 4.00K in taxes.

Athanase Innovation AB EV to EBITDA ratio is -44.76, with an EV/FCF ratio of -11.32.

Athanase Innovation AB has kr310.64M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -kr310.64M billion.

Gross margin is 97.79%, with operating margin of -13.40%, and net profit margin of -11.11%.

The average price target for Athanase Innovation AB is ―, which is 11.43% higher than the current price. The consensus rating is ―